Clinical Trials Directory

Trials / Completed

CompletedNCT02156700

Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors

Quantitative Real-time Ultrasound Elastography (Shear Wave Elastography - SWE™) for Characterisation of Liver Tumors

Status
Completed
Phase
Study type
Observational
Enrollment
196 (actual)
Sponsor
University Hospital Dubrava · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Shear Wave Elastography (SWE™) is a quantitative elastography method for measuring tissue stiffness. The difference in stiffness between benign and malignant tumors has been demonstrated by other elastography methods (acoustic radiation force impulse imaging, transient elastography and/or magnetic resonance elastography). The investigators hypothesized that benign liver tumors are softer than malignant liver tumors measured by SWE™, allowing differentiation between the two by tumor stiffness expressed in kilopascal (kPa). In this study benign and malignant liver tumors will be evaluated in five groups: 1) hemangioma and 2) focal nodular hyperplasia (FNH) representing the most common benign liver tumors; 3) metastases and 4) cholangiocarcinoma (CCC), both presenting malignant tumors mostly appearing in otherwise healthy liver, and 5) hepatocellular carcinoma (HCC) mostly occurring in cirrhotic liver, which can potentially influence elastographic measurements therefore querying the appropriateness of comparison between tumors in healthy and cirrhotic liver. Enrolled patients will undergo transabdominal ultrasonography and SWE™ examination. The tumor stiffness will be measured five times for each tumor. Additionally, surrounding liver parenchyma stiffness will be measured. The nature of the liver tumor will be defined through a standard diagnostic workup according to current guidelines, including contrast enhanced multi-slice CT, MRI and/or cytology/histology, as applicable. In the final analysis the mean tumor stiffness and tumor-parenchyma ratio will be calculated for each group as well as for benign and malignant tumors separately, and cut-off values for the differentiation of various groups will be derived. The clinical value of the method will be appraised based on specificity, sensitivity, positive and negative predictive values, and AUC.

Conditions

Interventions

TypeNameDescription
PROCEDUREShear wave elastographyMeasurement of tumor stiffness by Shear wave elastography - SWE™

Timeline

Start date
2013-09-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-06-05
Last updated
2015-12-24

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT02156700. Inclusion in this directory is not an endorsement.